<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Medical Genetics</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4A65E0B4-CFB1-460D-A8A7-88A965B56E69"><gtr:id>4A65E0B4-CFB1-460D-A8A7-88A965B56E69</gtr:id><gtr:firstName>Alan</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Bird</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B250B6AF-EAE4-4DDE-8FA5-308002D1E226"><gtr:id>B250B6AF-EAE4-4DDE-8FA5-308002D1E226</gtr:id><gtr:firstName>John</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Yates</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09FB4996-FA51-4A97-BED8-85703615B71F"><gtr:id>09FB4996-FA51-4A97-BED8-85703615B71F</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Clayton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/54EBF2BB-2BE7-407F-979C-D650BCFD38DA"><gtr:id>54EBF2BB-2BE7-407F-979C-D650BCFD38DA</gtr:id><gtr:firstName>Anthony</gtr:firstName><gtr:otherNames>Thomas</gtr:otherNames><gtr:surname>Moore</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7AA53DFF-4CE6-4404-8584-361D6533EFEB"><gtr:id>7AA53DFF-4CE6-4404-8584-361D6533EFEB</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:surname>Day</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0BAAB362-6169-494D-B44C-9A9A56971C78"><gtr:id>0BAAB362-6169-494D-B44C-9A9A56971C78</gtr:id><gtr:firstName>Shomi</gtr:firstName><gtr:surname>Bhattacharya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0000067"><gtr:id>55DD553B-1A6C-484E-80C1-4877657F39C3</gtr:id><gtr:title>Genetic Susceptibility to Age-Related Macular Degeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0000067</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1846207</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>C3 paper - media coverage</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>A08B2256-0F01-4A48-A29B-6AA9A3BF4D32</gtr:id><gtr:impact>Press release and several media interviews following publication of our New England Journal of Medicine article

Coverage on local radio, in national newspapers (Sun, Daily Mail, Guardian) and on BBC News website.</gtr:impact><gtr:outcomeId>62E1DA1B66C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Macular Disease Society newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>AFCBD02B-4A56-4B7C-B34C-1D76CDFD4E51</gtr:id><gtr:impact>Article about research to Macular Disease Society newsletter

Positive feedback from Chief Executive of Macular Disease Society</gtr:impact><gtr:outcomeId>2B8FD95A7AD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>129408</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Guide Dogs for Blind Association</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Guide Dogs for Blind Association</gtr:fundingOrg><gtr:id>07ACF365-2A57-4626-842F-72BD735AED58</gtr:id><gtr:outcomeId>96AA2E578D30</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22428</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Macular Disease Society Project Grant</gtr:description><gtr:end>2007-10-02</gtr:end><gtr:fundingOrg>Macular Society</gtr:fundingOrg><gtr:id>7C1C2226-6371-4F79-8316-B6FC980A1DD5</gtr:id><gtr:outcomeId>6544A65F4D00</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>A variant in the complement C3 gene influences the risk of developing age-related macular degeneration.</gtr:description><gtr:grantRef>G0000067</gtr:grantRef><gtr:id>54071392-DCFD-46D3-9705-E75B6A82E661</gtr:id><gtr:impact>Cambridge Enterprise (on behalf of Cambridge University ) granted a licence to the Canadian company ArcticDx included genotyping of this C3 variant as part of their Macula Risk Test to determine an individual's risk of developing age-related macular degeneration (AMD). This test has been widely used in North America and is now being marketed in Europe. Individuals identified as being at high risk of developing AMD are offered regular screening, allowing early diagnosis and treatment. US Patent No. 8,114,592 was issued on 12 February 2012 but this was subsequently subject to legal challenge (Patent Interference No 105,897) resulting in a judgement by the US Patent and Trademark Office on 16 August 2013 that the discovery is unpatentable.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>BF2628E7CAD</gtr:outcomeId><gtr:patentId>US8114592 (but see below)?</gtr:patentId><gtr:protection>Patent granted</gtr:protection><gtr:title>C3 for AMD risk prediction</gtr:title><gtr:yearProtectionGranted>2012</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Our research showed that a genetic variant in the complement C3 gene predicts risk of developing age-related macular degeneration (AMD). This finding is being used, together with variants in other genes influencing risk of AMD, in the Macula-Risk test now being marketed by a Canadian company ArcticDx in Canada and the USA.</gtr:description><gtr:id>66D4041F-A0B6-4B5B-9CDC-8CFA20329BD9</gtr:id><gtr:impact>The test was launched in 2009 and there have been no studies published as yet to assess impact.</gtr:impact><gtr:outcomeId>4BD9967A7DF</gtr:outcomeId><gtr:stage>Wide-scale adoption</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>Genetic risk assessment for age-related macular degeneration</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:url>http://www.arcticdx.com/home/amd-genetic-testing</gtr:url><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Resource of patient samples for studying the genetics of age-related macular degeneration (AMD). This comprises DNA samples from over 900 clinically evaluated cases of AMD and over 400 examined controls. For both cases and controls data is available on family and smoking history and clinical findings including grading of fundus photographs. White cell pellets have been deposited at the European Collection of Animal Cell Cultures. Plasma samples have been stored on a subset of 411 cases and 277 controls.</gtr:description><gtr:id>4D88FF9B-E357-4953-A058-1926FF2D088D</gtr:id><gtr:impact>Two of our collaborators are using these samples for further research on AMD</gtr:impact><gtr:outcomeId>C86648C5722</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>AMD patient samples and data</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>247D7769-6BF9-4316-903A-BC1B012C296C</gtr:id><gtr:title>Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3720f6ab243a2dca02ececadcf8ea147"><gtr:id>3720f6ab243a2dca02ececadcf8ea147</gtr:id><gtr:otherNames>Cipriani V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16250_20_22694956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6E809D1-A9A2-4760-A609-4262DC74F7F1</gtr:id><gtr:title>Age-related macular degeneration: the importance of family history as a risk factor.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236cd1c73e69994b8fb9400338bf1a1a"><gtr:id>236cd1c73e69994b8fb9400338bf1a1a</gtr:id><gtr:otherNames>Shahid H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>e47pHYdEy9F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DBA92298-D636-420A-BD23-360B0DEDDBD8</gtr:id><gtr:title>A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b77f4cea729b0036e5b28985a21840a3"><gtr:id>b77f4cea729b0036e5b28985a21840a3</gtr:id><gtr:otherNames>Fritsche LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>56b4bcc2860684.03605269</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F53598A3-C625-45B2-800F-940609391A01</gtr:id><gtr:title>Age-related macular degeneration and the complement system.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d073ade4763b4cc45656e9750bb087e6"><gtr:id>d073ade4763b4cc45656e9750bb087e6</gtr:id><gtr:otherNames>Khandhadia S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>VXrT1Va5s4g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB5FAD5A-79CC-4283-8BF1-D5E6D4CE1FAE</gtr:id><gtr:title>Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5545c1a2cda80889664baf8ee3ca8c27"><gtr:id>5545c1a2cda80889664baf8ee3ca8c27</gtr:id><gtr:otherNames>Sepp T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>3EDDB89000F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>870DF030-65EA-4871-A468-D5ADB16E5A5E</gtr:id><gtr:title>Genetic variation in complement regulators and susceptibility to age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Immunobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3720f6ab243a2dca02ececadcf8ea147"><gtr:id>3720f6ab243a2dca02ececadcf8ea147</gtr:id><gtr:otherNames>Cipriani V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0171-2985</gtr:issn><gtr:outcomeId>kkzf8yY2SxX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B710DCF-62F3-4ED0-84AE-5E74DA3F877E</gtr:id><gtr:title>Charles Bonnet syndrome in age-related macular degeneration: the nature and frequency of images in subjects with end-stage disease.</gtr:title><gtr:parentPublicationTitle>Ophthalmic epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3896612d46efefe18d2cd72b65c0a539"><gtr:id>3896612d46efefe18d2cd72b65c0a539</gtr:id><gtr:otherNames>Khan JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0928-6586</gtr:issn><gtr:outcomeId>F4FBFB16825</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>424E309E-C77C-4F1A-9D88-EF803549438D</gtr:id><gtr:title>Comparing variant calling algorithms for target-exon sequencing in a large sample.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f0e7cd39b949de9f47703cee46ce5e"><gtr:id>73f0e7cd39b949de9f47703cee46ce5e</gtr:id><gtr:otherNames>Lo Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>5a325495c98de4.58917153</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7FFAFE80-A52A-41FC-9AA2-84341A98D89A</gtr:id><gtr:title>Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3896612d46efefe18d2cd72b65c0a539"><gtr:id>3896612d46efefe18d2cd72b65c0a539</gtr:id><gtr:otherNames>Khan JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>25FB5EA2F8D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C695E8D-505A-4AA6-9DEF-208A493093A6</gtr:id><gtr:title>Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3896612d46efefe18d2cd72b65c0a539"><gtr:id>3896612d46efefe18d2cd72b65c0a539</gtr:id><gtr:otherNames>Khan JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>02E9062F8EF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8029DB90-8BD1-4BB8-822B-AB50C3EAC4FB</gtr:id><gtr:title>Seven new loci associated with age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b77f4cea729b0036e5b28985a21840a3"><gtr:id>b77f4cea729b0036e5b28985a21840a3</gtr:id><gtr:otherNames>Fritsche LG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16250_20_23455636</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1F04DB5A-C47D-4863-9822-4835EEDD12A2</gtr:id><gtr:title>Association of C-Reactive Protein Genetic Polymorphisms With Late Age-Related Macular Degeneration.</gtr:title><gtr:parentPublicationTitle>JAMA ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3720f6ab243a2dca02ececadcf8ea147"><gtr:id>3720f6ab243a2dca02ececadcf8ea147</gtr:id><gtr:otherNames>Cipriani V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2168-6165</gtr:issn><gtr:outcomeId>5a34f57d130ab2.65392878</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12A374C2-C409-41A7-BF15-A0B9087F1CF0</gtr:id><gtr:title>Genetic variants within chromosome 4q28.3 are not reproducibly associated with age-related macular degeneration (AMD).</gtr:title><gtr:parentPublicationTitle>Acta ophthalmologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d0058b9873c2884fe0fb044f03c6b70"><gtr:id>6d0058b9873c2884fe0fb044f03c6b70</gtr:id><gtr:otherNames>Gibson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1755-375X</gtr:issn><gtr:outcomeId>sk7PqiMcRo8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB0ED07E-0502-4C4F-BA86-7D3CBA1E6845</gtr:id><gtr:title>Complement C3 variant and the risk of age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a563c18be123bc265f8fa9a0fb95379d"><gtr:id>a563c18be123bc265f8fa9a0fb95379d</gtr:id><gtr:otherNames>Yates JR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn><gtr:outcomeId>FC36B08963C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D22EF7B8-A787-4CB3-93BF-BB1751EF2619</gtr:id><gtr:title>Complement factor D in age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00907fb3dc7bf170333a9e928629f700"><gtr:id>00907fb3dc7bf170333a9e928629f700</gtr:id><gtr:otherNames>Stanton CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>ZemwKHvabpc</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1ADCC820-A8C9-45A6-BBED-5A3FE53C8571</gtr:id><gtr:title>Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies.</gtr:title><gtr:parentPublicationTitle>Human mutation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1578f0255e4dea71ffc3de53a6f650d2"><gtr:id>1578f0255e4dea71ffc3de53a6f650d2</gtr:id><gtr:otherNames>McKay GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1059-7794</gtr:issn><gtr:outcomeId>nmhAWU8sVs6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FFBBD83-B713-4030-BF8A-926C5BC7C971</gtr:id><gtr:title>Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people.</gtr:title><gtr:parentPublicationTitle>American journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1578f0255e4dea71ffc3de53a6f650d2"><gtr:id>1578f0255e4dea71ffc3de53a6f650d2</gtr:id><gtr:otherNames>McKay GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0002-9262</gtr:issn><gtr:outcomeId>AhL8Aybr6gg</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91B9D8FA-E9EC-4226-96AA-7F5F3CB3947E</gtr:id><gtr:title>Analysis of copy number variation at DMBT1 and age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>BMC medical genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8572e735ea379400c17eb20c116ef05a"><gtr:id>8572e735ea379400c17eb20c116ef05a</gtr:id><gtr:otherNames>Polley S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2350</gtr:issn><gtr:outcomeId>58bed3c451f674.24563458</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4E56530B-AA7E-43A5-865F-DCF254512DB5</gtr:id><gtr:title>No evidence of association between complement factor I genetic variant rs10033900 and age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>European journal of human genetics : EJHG</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3720f6ab243a2dca02ececadcf8ea147"><gtr:id>3720f6ab243a2dca02ececadcf8ea147</gtr:id><gtr:otherNames>Cipriani V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1018-4813</gtr:issn><gtr:outcomeId>q31vi3ffJjo</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0088C11F-B544-437A-A7D2-C85B0E016687</gtr:id><gtr:title>Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype.</gtr:title><gtr:parentPublicationTitle>International journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cf513374aefc525998bd45102347c56"><gtr:id>4cf513374aefc525998bd45102347c56</gtr:id><gtr:otherNames>Sofat R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0300-5771</gtr:issn><gtr:outcomeId>pm_16250_20_22253316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C3A0A7-9F43-4366-BF56-5F2492890034</gtr:id><gtr:title>Identification of a rare coding variant in complement 3 associated with age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17d79a7f0c1b7be4421df7a5683cde3e"><gtr:id>17d79a7f0c1b7be4421df7a5683cde3e</gtr:id><gtr:otherNames>Zhan X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16250_20_24036949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8175182F-460C-4753-A79F-D291B3EFB579</gtr:id><gtr:title>Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3982d000592c7bb3d227998a20f0c93b"><gtr:id>3982d000592c7bb3d227998a20f0c93b</gtr:id><gtr:otherNames>Ansari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16250_20_23873044</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0000067</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>